Table 1 Baseline characteristics of participants by group.

From: Reconsolidation-based treatment for fear of public speaking: a systematic pilot study using propranolol

 

Mean (SD)

BF10

Duration

Prop

Placebo

t

U

r (BF10)

tau (BF10)

Baseline measures

Age

21.65 (2.78)

22.10 (1.92)

0.33

0.34

0.01 (0.16)

0.02 (0.17)

LSASAvoid

21.35 (9.66)

21.35 (9.60)

0.28

0.29

0.20 (0.53)

0.13 (0.50)

LSASFear

27.63 (9.81)

25.65 (10.54)

0.34

0.36

0.28 (1.59)

0.19 (1.53)

ASI

17.05 (8.11)

18.10 (9.42)

0.30

0.28

−0.04 (0.17)

−0.03 (0.17)

PRPSA

138.33 (9.20)

138.70 (9.49)

0.28

0.28

0.09 (0.20)

0.03 (0.18)

STAI-S

43.55 (8.61)

40.25 (9.68)

0.58

0.62

0.05 (0.17)

0.04 (0.18)

STAI-T

43.30 (6.98)

45.50 (11.71)

0.39

0.64

−0.04 (0.17)

−0.04 (0.18)

PHQ-9

4.00 (2.62)

3.95 (2.65)

0.28

0.26

0.12 (0.25)

0.10 (0.31)

RSES

19.20 (3.84)

19.70 (5.45)

0.30

0.32

−0.10 (0.21)

−0.07 (0.23)

STAI-S S2

38.65 (10.77)

41.05 (10.75)

0.36

0.36

NA

NA

Additional single items

Confidence

6.15 (1.72)

6.25 (1.94)

0.28

0.32

−0.03 (0.16)

−0.02 (0.17)

RuminationWait

55.80 (25.36)

61.95 (24.00)

0.39

0.32

0.46 (123.92)

0.32 (95.32)

RuminationDay

42.93 (24.77)

38.75 (24.88)

0.32

0.35

0.33 (3.72)

0.22 (3.38)

Versus expected

−17.78 (45.38)

−21.53 (41.82)

0.30

0.29

−0.11 (0.23)

−0.06 (0.22)

Versus expectedAbsolute Score

39.17 (28.40)

37.88 (26.77)

0.30

0.34

0.01 (0.17)

−0.02 (0.18)

  1. BF10 Bayes Factor for difference between groups/relationship with Duration, prop Propranolol group, r Pearson’s r, SD standard deviation, t Bayesian independent samples’ t test, tau Kendall’s tau, U Bayesian Mann–Whitney U test, LSAS Liebowitz Social Anxiety Scale, ASI anxiety sensitivity index, PRPSA personal report of public speaking anxiety, STAI-S/T state-trait anxiety inventory—state/trait, PHQ-9 patient health questionnaire 9, RSES Rosenberg Self-esteem Scale.
Back to article page